Genus plc

LSE GNS.L

Genus plc Net Cash Used Provided By Financing Activities for the year ending June 30, 2024: USD -3.54 M

Genus plc Net Cash Used Provided By Financing Activities is USD -3.54 M for the year ending June 30, 2024, a 84.66% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Genus plc Net Cash Used Provided By Financing Activities for the year ending June 30, 2023 was USD -23.10 M, a -186.64% change year over year.
Genus plc Net Cash Used Provided By Financing Activities for the year ending June 30, 2022 was USD 26.66 M, a 235.79% change year over year.
Genus plc Net Cash Used Provided By Financing Activities for the year ending June 30, 2021 was USD -19.64 M, a 31.45% change year over year.
Genus plc Net Cash Used Provided By Financing Activities for the year ending June 30, 2020 was USD -28.64 M, a -265.90% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

LSE: GNS.L

Genus plc

CEO	Mr. Jorgen Kokke
IPO Date	July 6, 2000
Location	United Kingdom
Headquarters	Matrix House
Employees	3,500
Sector	Consumers Staples
Industries Meat Agriculture Biotechnology Dairy & Milk Pet Food Plastics Tobacco Vaccines

Description

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Key trends

Past 5 years